Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other hematologic neoplasm 1 Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 158 Pemetrexed 135 Cisplatin 115 pembrolizumab 99 Docetaxel 94 Paclitaxel 89 Gemcitabine 63 Erlotinib Hydrochloride 60 Radiotherapy 55 Nivolumab 55 Bevacizumab 46 Etoposide 42 atezolizumab 33 Radiosurgery 33 durvalumab 27 Cyclophosphamide 22 Vinorelbine 21 Ipilimumab 21 Radiation 20 Taxes 17 130-nm albumin-bound paclitaxel 17 Albumin-Bound Paclitaxel 16 Gefitinib 14 Irinotecan 13 Drug Therapy 13 osimertinib 12 avelumab 12 Magnetic Resonance Spectroscopy 12 Dexamethasone 12 Cetuximab 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × ficlatuzumab × Thoracic × Clear all

NCT02318368 2020-10-22

FOCAL

AVEO Pharmaceuticals, Inc.

Phase 2 Terminated

10 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡